R21DE029303 (SCOFIELD, ROBERT HAL)May 1, 2020 - Apr 30, 2022 NIH
ENBA2 in the pathogenesis of Sjogren's Syndrome
Role: Principal Investigator |
|
I01CX001877 (SCOFIELD, ROBERT HAL)Apr 1, 2020 - Mar 31, 2024 NIH
Autoimmunity in Post-Traumatic Stress Disorder
Role: Principal Investigator |
|
IS1BX005038 (SCOFIELD, ROBERT HAL)Sep 1, 2019 - Sep 30, 2020 NIH
ShEEP Request for Peggy Sue by Bio-Techne
Role: Principal Investigator |
|
R21DE026877 (SCOFIELD, ROBERT HAL)Aug 1, 2017 - Jul 31, 2019 NIH
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome
Role: Principal Investigator |
|
I01BX001451 (SCOFIELD, ROBERT HAL)Apr 1, 2012 - Sep 30, 2025 NIH
Sex Chromosome Aneuploidies in Autoimmune Disease
Role: Principal Investigator |
|
R01DE017561 (SCOFIELD, R HAL)Aug 1, 2006 - May 31, 2011 NIH
Sjogren's model with anti-Ro/La and Salivary Pathology and Dysfunction
Role: Principal Investigator |
|
R01AR053734 (SCOFIELD, R HAL)Apr 12, 2006 - Jan 31, 2012 NIH
The X Chromosome in Systemic Lupus Erythematosus
Role: Principal Investigator |
|
K24AR049743 (SCOFIELD, R HAL)Jul 1, 2003 - Dec 30, 2008 NIH
Genetics of Severe Systemic Lupus Erythematosus (SLE) defined by thrombocytopenia
Role: Principal Investigator |
|
R55AR047341 (SCOFIELD, R HAL)Sep 30, 2001 - Feb 28, 2004 NIH
A MODEL OF SJOGREN'S SYNDROME WITH ANTI-RO/LA ANTIBODIES
Role: Principal Investigator |
|
F06TW002260 (SCOFIELD, R HAL)Sep 18, 1998 NIH
B27 RESTRICTED T CELL RESPONSE TO B27 MIMIC PEPTIDES
Role: Principal Investigator |
|
R29AR042532 (SCOFIELD, R HAL)Apr 1, 1996 - Mar 31, 2002 NIH
B27 BINDING BACTERIAL AND SELF PEPTIDES IN B27 ARTHRITIS
Role: Principal Investigator |
|
K11AR001844 (SCOFIELD, R HAL)Mar 15, 1992 - Feb 28, 1998 NIH
ORIGIN OF ANTIRO/SSA ANTIBODY
Role: Principal Investigator |